NCT01974336View on ClinicalTrials.gov

The Preventative and Therapeutical Effect of Ursodeoxycholic Acid(UDCA) to Short Bowel Syndrome Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

April 30, 2016

Study Completion Date

September 30, 2016

Conditions

Short Bowel Syndrome

Interventions

DRUG

ursodeoxycholic acid

Trial Locations (1)

200002

Jinling Hospital, Nanjing

All Listed Sponsors

collaborator

National Natural Science Foundation of China

OTHER_GOV

lead

Jinling Hospital, China

OTHER

NCT01974336 - The Preventative and Therapeutical Effect of Ursodeoxycholic Acid(UDCA) to Short Bowel Syndrome Patients | Biotech Hunter | Biotech Hunter